Black Creek Investment Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-869,173
Closed -$30.4M 17
2014
Q3
$30.4M Sell
869,173
-775,312
-47% -$26.6M 3.5% 13
2014
Q2
$54M Sell
1,644,485
-117,532
-7% -$4.02M 5.68% 8
2014
Q1
$64.9M Sell
1,762,017
-695,017
-28% -$25.5M 7.1% 7
2013
Q4
$94.3M Sell
2,457,034
-811,624
-25% -$25.6M 11.1% 1
2013
Q3
$89.6M Sell
3,268,658
-253,207
-7% -$6M 15.22% 1
2013
Q2
$73.8M Buy
+3,521,865
New +$68.8M 13.02% 1

Other funds holding WX

Black Creek Investment Management's WX Position: Q4 2014 in Review

Black Creek Investment Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2014, closing a stake of 869,173 shares — an estimated $30.4M sold.

Black Creek Investment Management first reported a position in WX in Q2 2013 and held it in 6 quarters. The position peaked at $94.3M in Q4 2013. 165 funds tracked by Wall St. Rank hold WX as of Q4 2014.

  • Black Creek Investment Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2014 after selling out during the quarter.
  • Black Creek Investment Management sold 869,173 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2014, an estimated $30.4M.
  • Black Creek Investment Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 6 quarters.
  • Black Creek Investment Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $94.3M in Q4 2013.
  • 165 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2014.

Based on Black Creek Investment Management's 13F filing for Q4 2014, filed 4 Feb 2015.